Body iron and individual iron prophylaxis in pregnancy—should the iron dose be adjusted according to serum ferritin? Nils MilmanKeld-Erik BygAnne-Mette Hvas Original Article 30 May 2006 Pages: 567 - 573
Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas Jin Tae JungDong Hwan KimKyu Bo Lee Original Article 04 May 2006 Pages: 575 - 581
Identification and characterization of HLA-class-I-restricted T-cell epitopes in the putative tumor-associated antigens P21-activated serin kinase 2 (PAK2) and cyclin-dependent kinase inhibitor 1A (CDKN1A) Guzi LiMichael HundemerMathias Witzens-Harig Original Article 23 May 2006 Pages: 583 - 590
Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy Jeroen S. GoedeRudolf BenzHermann Heimpel Original Article 10 June 2006 Pages: 591 - 595
Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma Iñigo EspinosaJavier BrionesJorge Sierra Original Article 08 July 2006 Pages: 597 - 603
Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trial Zaher K. OtrockSami T. AzarAli T. Taher Original Article 08 July 2006 Pages: 605 - 609
Constitutional pericentric inversion of chromosome 9 and hematopoietic recovery after allogeneic stem cell transplantation K. N. ManolaN. HarhalakisC. Sambani Original Article 07 June 2006 Pages: 611 - 615
Severe diarrhoea during Campath-1H treatment for refractory cutaneous T-cell lymphoma Gaia GoteriSerena RupoliItalo Bearzi Letter to the Editor 04 July 2006 Pages: 617 - 619
Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder W. J. F. M van der VeldenN. M. A. BlijlevensP. E. Verweij Letter to the Editor 07 June 2006 Pages: 621 - 623
Rituximab as first line treatment for MALT lymphoma of extraocular muscles Leonidas BenetatosVasiliki AlymaraKonstantinos L. Bourantas Letter to the editor 12 May 2006 Pages: 625 - 626
Transient severe symptomatic pulmonary hypertension as onset symptom in multiple myeloma Carlo RostagnoStefania Ciolli Letter to the Editor 17 May 2006 Pages: 627 - 628
Disseminated herpes virus (HSV-2) infection with rhabdomyolysis and hemophagocytic lymphohistiocytosis in a patient with bone marrow failure syndrome K. RamasamyZ. Y. LimA. Pagliuca Letter to the Editor 17 May 2006 Pages: 629 - 630
Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab Dimitri FliegerSabine HainkeWolfgang Fischbach Letter to the Editor 29 June 2006 Pages: 631 - 632
Acute splenic sequestration crisis in an adult with sickle β-thalassemia Prasad Rao KoduriPaula Kovarik Letter to the Editor 17 May 2006 Pages: 633 - 635
The hematopathological basis for studying effects of the demethylating agent 5-aza-2′-deoxycytidine (decitabine) in myelodysplasia Hans Eckart SchaeferMicheal Lübbert Erratum 05 July 2006 Pages: 637 - 637
Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO) Olaf PenackThomas BeinertHelmut Ostermann Erratum 30 June 2006 Pages: 639 - 639
7th International Lübeck Conference on the Pathophysiology and Pharmacology of Erythropoietin and other Hemopoietic Growth Factors Abstracts 25 July 2006 Pages: 641 - 669
